87 related articles for article (PubMed ID: 23357434)
1. Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis.
Gong LL; Fang LH; Wang HY; Peng JH; Si K; Zhu J; Han FF; Wang YH; Du GH; Pei LX; Liu LH
Steroids; 2013 Apr; 78(4):401-8. PubMed ID: 23357434
[TBL] [Abstract][Full Text] [Related]
2. Association of ABCB1/MDR1 polymorphisms in patients with glucocorticoid-induced osteonecrosis of the femoral head: Evidence for a meta-analysis.
Zhou Z; Hua Y; Liu J; Zuo D; Wang H; Chen Q; Zheng L; Cai Z
Gene; 2015 Sep; 569(1):34-40. PubMed ID: 25791493
[TBL] [Abstract][Full Text] [Related]
3. Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.
Liang XN; Xie L; Cheng JW; Tan Z; Yao J; Liu Q; Su W; Qin X; Zhao JM
Thromb Res; 2013 Aug; 132(2):158-63. PubMed ID: 23856555
[TBL] [Abstract][Full Text] [Related]
4. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
Gong LL; Peng JH; Han FF; Zhu J; Fang LH; Wang YH; Du GH; Wang HY; Liu LH
Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of ischemic stroke: a meta-analysis.
Tsantes AE; Nikolopoulos GK; Bagos PG; Tsiara CG; Kapsimali V; Travlou A; Vaiopoulos G
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):497-504. PubMed ID: 17581326
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.
Yioti GG; Panagiotou OA; Vartholomatos GA; Kolaitis NI; Pappa CN; Evangelou E; Stefaniotou MI
Ophthalmic Genet; 2013 Sep; 34(3):130-9. PubMed ID: 23289804
[TBL] [Abstract][Full Text] [Related]
7. Analysis of -675 4 g/5 G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients.
Kowal K; Bodzenta-Lukaszyk A; Pampuch A; Szmitkowski M; Zukowski S; Donati MB; Iacoviello L
J Investig Allergol Clin Immunol; 2008; 18(4):284-92. PubMed ID: 18714537
[TBL] [Abstract][Full Text] [Related]
8. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Contributes to Osteonecrosis of the Femoral Head Susceptibility: Evidence from a Systematic Review and Meta-analysis.
Sobhan MR; Mahdinezhad-Yazdi M; Moghimi M; Aghili K; Jafari M; Zare-Shehneh M; Neamatzadeh H
Arch Bone Jt Surg; 2018 Nov; 6(6):468-477. PubMed ID: 30637301
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
Bagos PG
Mol Hum Reprod; 2009 Jan; 15(1):19-26. PubMed ID: 19066200
[TBL] [Abstract][Full Text] [Related]
11. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
[TBL] [Abstract][Full Text] [Related]
12. 4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries.
Koch W; Schrempf M; Erl A; Mueller JC; Hoppmann P; Schömig A; Kastrati A
Thromb Haemost; 2010 Jun; 103(6):1170-80. PubMed ID: 20352162
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation.
Ma Z; Paek D; Oh CK
Clin Exp Allergy; 2009 Aug; 39(8):1136-44. PubMed ID: 19438580
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
Guan LX; Du XY; Wang JX; Wang RL; Wu ZL; Jiang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism in the fibrinolytic system and endometriosis.
Bedaiwy MA; Falcone T; Mascha EJ; Casper RF
Obstet Gynecol; 2006 Jul; 108(1):162-8. PubMed ID: 16816071
[TBL] [Abstract][Full Text] [Related]
17. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
[TBL] [Abstract][Full Text] [Related]
18. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome.
Armangil D; Yurdakök M; Okur H; Gürgey A
Clin Appl Thromb Hemost; 2011 Aug; 17(4):352-7. PubMed ID: 20460339
[TBL] [Abstract][Full Text] [Related]
20. [Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].
Gong R; Liu Z; Chen Z; Li L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):1-5. PubMed ID: 11836675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]